Sofinnova Venture Partners X L.P. 13D and 13G filings for Bolt Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 2:14 pm Purchase | 2021-02-04 | 13D | Bolt Biotherapeutics, Inc. BOLT | Sofinnova Venture Partners X L.P. | 2,754,437 8.000% | 2,754,437 (New Position) | Filing |